Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00026182
Status:
COMPLETED
Last Update Posted:
2013-08-26
First Post:
2001-11-09
Brief Title:
Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkins Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Splenic Marginal Zone Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Small Lymphocytic Lymphoma |
Keywords: